Drug Shortage Report for APO-ESOMEPRAZOLE

Last updated on 2020-03-03 History
Report ID 105330
Drug Identification Number 02339099
Brand name APO-ESOMEPRAZOLE
Common or Proper name ESOMEPRAZOLE
Company Name APOTEX INC
Active Ingredient(s) ESOMEPRAZOLE
Strength(s) 20MG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL
Packaging size 100 BTL
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-02-03
Estimated end date 2020-03-17
Actual end date 2020-03-02
Shortage status Resolved
Updated date 2020-03-03
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-03-03 French Compare
v3 2020-03-03 English Compare
v2 2020-02-05 French Compare
v1 2020-02-05 English Compare